Mayo Clinic Proceedings Home


        Incorrect dosage in Tables 2 and 3: In the article by Pelosof and Gerber entitled “Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment,” published in the September 2010 issue of Mayo Clinic Proceedings (Mayo Clin Proc. 2010;85(9):838-854), an incorrect dosage was provided for intravenous immunoglobulin (IVIG) under treatment options in Tables 2 and 3. The dosage for IVIG as treatment for limbic encephalitis, paraneoplastic cerebellar degeneration, Lambert-Eaton myasthenia syndrome, myasthenia gravis, and subacute (peripheral) sensory neuropathy in Table 2 and for dermatomyositis, leukocytoclastic vasculitis, and paraneoplastic pemphigus in Table 3 should have read: IVIG, 400-1000 mg/kg/d to total 2-3 g/kg. A corrected version of both Tables is available as a data supplement (“Corrected Tables”) attached to this article at
        To read this article in full you will need to make a payment

        Purchase one-time access:

        Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
        One-time access price info
        • For academic or personal research use, select 'Academic and Personal'
        • For corporate R&D use, select 'Corporate R&D Professionals'


        Subscribe to Mayo Clinic Proceedings
        Already a print subscriber? Claim online access
        Already an online subscriber? Sign in
        Institutional Access: Sign in to ScienceDirect